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Abstract
Background: RT-qPCR analysis is a widely used method for the analysis of mRNA expression throughout the field
of mesenchymal stromal cell (MSC) research. Comparison between MSC studies, both in vitro and in vivo, are
challenging due to the varied methods of RT-qPCR data normalization and analysis. Therefore, this study focuses
on putative housekeeping genes for the normalization of RT-qPCR data between heterogeneous commercially
available human MSC, compared with more homogeneous populations of MSC such as MIAMI and RS-1 cells.
Results: Eight genes including; ACTB, B2M, EF1a, GAPDH, RPL13a, YWHAZ, UBC and HPRT1 were tested as possible
housekeeping genes based on their expression level and variability. EF1a and RPL13a were validated for RT-qPCR
analysis of MIAMI cells during expansion in varied oxygen tensions, endothelial differentiation, neural precursor
enrichment, and during the comparison with RS-1 cells and commercially available MSC. RPL13a and YWHAZ were
validated as normalization genes for the cross-species analysis of MIAMI cells in an animal model of focal ischemia.
GAPDH, which is one of the most common housekeeping genes used for the normalization of RT-qPCR data in the
field of MSC research, was found to have the highest variability and deemed not suitable for normalization of
RT-qPCR data.
Conclusions: In order to make comparisons between heterogeneous MSC populations, as well as adult stem cell
like MSC which are used in different laboratories throughout the world, it is important to have a standardized,
reproducible set of housekeeping genes for RT-qPCR analysis. In this study we demonstrate that EF1a, RPL13a and
YWHAZ are suitable genes for the RT-qPCR analysis and comparison of several sources of human MSC during in
vitro characterization and differentiation as well as in an ex vivo animal model of global cerebral ischemia. This will
allow for the comparative RT-qPCR analysis of multiple MSC populations with the goal of future use in animal
models of disease as well as tissue repair.
Background
Human bone marrow-derived multipotent mesenchymal
stromal cells (MSC) represen tau n i q u eb u th e t e r o g e -
neous population of progenitor cells (adult stem cells)
with self-renewal properties and multilineage differentia-
tion potential [1]. Various isolation, selection, and cul-
ture conditions have been used (review [2]) in order to
develop more homogeneous populations of human MSC
such as MIAMI cells [3], MAPC, MASC [4], SSEA-4+
MSC [5], CD133+ Selected MSC [6], and RS-1 cells [7].
These sub-populations of MSC are characterized by
increased self-renewal potential and the ability to differ-
entiate not only into mature cells found in mesodermal-
derived tissues (SSEA-4+ MSC), but also in ectodermal-
and endodermal-derived tissues (MIAMI cells, MAPC,
MACS, CD133+ Selected MSC).
The in vitro, ex vivo,a n din vivo characterization of
MSC requires the analysis of gene expression profiles in
order to understand their underlying mechanisms of
self-renewal during long term expansion, differentiation
into all three germinal lineages, as well as their tissue
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Quantitative real time RT-PCR (RT-qPCR) is often used
as a tool to determine the relative change of a target
genes mRNA expression, which is normalized against a
highly expressed and stable reference gene. Due to its
affordability, ease of use, and reproducibility, RT-qPCR
is used widely throughout the field of MSC research.
However, the validity of gene expression data deter-
mined by RT-qPCR is dependent on the optimal selec-
tion of at least two or more reference genes for
normalization, characterized by high expression levels
and low expression variability [8,9].
The purpose of this study was to validate at least two
reference genes suitable for the normalization of RT-
qPCR gene expression data in MSC such as MIAMI
cells under various conditions including: (1) low and
ambient oxygen tension (pO2), (2) expansion and or dif-
ferentiation, (3) ex vivo or in vivo animal disease models,
(4) determination of consistent gene expression profiles
across several MSC subpopulation and preparations.
Due to the varied nature of gene expression, we selected
8 genes involved in different cellular functions and
widely employed as normalization genes in the litera-
ture. These genes include: transcript translation (EF1a,
RPL13a), cell motility/cytoskeleton (ACTB), immune
response/binds MHC class I (B2M), metabolism/glycoly-
sis (GAPDH), nucleotide salvaging/purine synthesis
(HPRT1), signal transduction (YWHAZ), and protein
degradation (UBC) (Table 1, 2). A previous study also
showed that, UBC, RPL13a,a n dYWHAZ are 3 suitable
reference genes for RT-qPCR analysis of whole bone
marrow aspirates [8].
Heterogeneous MSC and primitive more homoge-
neous population of bone marrow derived adult stem
cell (MIAMI cells, RS-1 cells, MAPC etc.) are isolated
from whole bone marrow aspirates and are a sub-frac-
tion of the total bone marrow cell population. Reviewing
the literature on bone marrow-derived adult stem cell
research, GAPDH, ACTB, B2M and EF1a were found to
be the most commonly used genes for normalization of
RT-qPCR data (Table 1). We validated the stability of
the known whole bone marrow RT-qPCR reference
genes UBC, RPL13a,a n dYWHAZ [8], as well as the
previously mentioned genes used in MSC research. We
analyzed the stability and expression profile of each
reference gene in MIAMI cells using low oxygen tension
(pO2), growth factor induced neural precursor enrich-
ment, under growth factor stimulated endothelial differ-
entiation conditions, and in an ex vivo rat hippocampal
organotypic model of global cerebral ischemia. In addi-
tion, we compared the results in MIAMI cells to
another population of bone marrow-derived adult stem
cells, RS-1 cells [7] as well as commercially available
MSC.
Adult stem cells such as bone marrow derived MIAMI
cells are a promising source for cell therapy based
approaches due to their immunomodulatory properties
as well as their potential to differentiate into mature
somatic tissues [10]. They are also not burdened by
ethical restrictions or problems such as partial vs. full
epigenetic reprogramming, tumorgenicity potential, nor
due to controversial clinical functionality associated with
embryonic stem cells (ESC) and induced pluripotent
stem (iPS) cells [11,12]. Our study identified EF1a and
Table 1 Review of normalization “housekeeping” genes used for RT-qPCR analysis of mesenchymal stromal cells
RT-qPCR
Gene Full Name Reference
SMa-
actin
alpha-2 smooth muscle aorta actin Ross et al 2006[26]
ACTB b-actin Dickhut et al 2009 [27], Murthy et al 2008 [28]
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
Block et al 2009 [29], Gang et al 2009 [30], *Lu et al2009 [31], Leonardi et al 2009 [32], Schneider et al
2009
[33], Tan et al 2009 [34], Corcoran et al 2008 [35],
B2M b2-microglobulin Briquet et al 2009 [36]
Semi-quantitative or normal PCR
Gene Full Name Reference
EF1a Eukaryotic translational elongation
factor 1 alpha
D’Ippolito et al 2006 [15,37,38], D’Ippolito et al 2004 [3]
ACTB b-actin Riekstina et al 2009 [39], Gang et al 2007 [5], Shim et al 2004 [40]
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
Drost et al 2009 [41], Tang et al 2008 [42], Greco et al 2008 [43], Trzaska et al 2008 [44], Betrami et al
2007 [4], Greco et al 2007 [45], Tatard et al 2007 [17], Trzaska et al 2007 [46], Muguruma et al 2003 [47]
B2M b2-microglobulin Pozzobon et al 2009 [6], Martinez et al 2007 [48]
* used more than one normalization gene (GAPDH and 18 S RNA)
Table#1: Literature searches were conducted through PubMed Central http://www.pubmed.com. Representative manuscripts were selected which used
quantitative real time PCR (RT-qPCR) or semi-quantitative PCR analyses for the analysis of gene expression in human bone marrow derived adult stem cells or
classical MSC to determine commonly used normalization “housekeeping” genes.
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of MSC. These results are important because they will
allow for the valid, reproducible, and comparative analy-
sis of gene expression data in an increasingly expanding
area of MSC research, especially for future clinical use.
Results
Characterization of 8 putative normalization gene
expression levels in MIAMI cells
In MIAMI cells expanded at low oxygen tension (3%
pO2), real time quantitative PCR (RT-qPCR) analysis
was used to determine the expression levels and rela-
tive fold difference between 8 putative normalization
genes; ACTB, B2M, EF1a,G A P D H ,R P L 1 3 a ,Y W H A Z ,
UBC and HPRT1. HPRT1 had the lowest expression
level relative to the 7 other genes analyzed and was set
to the value of 1 in order to compare with the other
genes. EF1a (104.2 ± 0.3) and GAPDH (89.4 ± 1.1) had
the highest relative mRNA expression levels or fold
difference above HPRT1,f o l l o w e db yRPL13a (28.5 ±
0.3), YWHAZ (17.8 ± 0.4), B2M (11.9 ± 0.42), UBC
(10.7 ± 0.5) and ACTB (8.56 ± 0.47) (Figure# 1).
Alpha-2 smooth muscle aorta actin (SMa-actin)i s
another gene used for RT-qPCR normalization (Table
1) but was not detected in MIAMI cells under expan-
sion conditions.
The average CP standard deviation was next calcu-
lated to determine the stability of gene expression. The
standard deviation of the crossing point (CP) for each
gene per independent experiment (ExpSTDEV) was
Table 2 Genes used for Real Time RT-qPCR analysis
Gene Full Name Accession
Number
Sequence Cellular Function Reference
Normalization Genes
ACTB Beta-actin NM_001101 F = 5’-CTGGAACGGTGAAGGTGACA-3’
R=5 ’-AAGGGACTTCCTGTAACAATGCA-3’
Cell motility,
structure, integrity
EF1a Eukaryotic translational elongation
factor 1 alpha
NM_001402 F = 5’-AGGTGATTATCCTGAACCATCC-3’
R=5 ’-AAAGGTGGATAGTCTGAGAAGC-3’
Translation
B2M Beta-2-microglobulin NM_004048 F = 5’-TGCTGTCTCCATGTTTGATGTATCT-3’
R=5 ’-TCTCTGCTCCCCACCTCTAAGT-3’
Immune Response:
Binds MHC class 1
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
NM_002046 F = 5’-TGCACCACCAACTGCTTAGC-3’
R=5 ’-GGCATGGACTGTGGTCATGAG-3’
Metabolism:
Glycolysis
[8]
HPRT1 Hypoxanthine
phosphoribosyltransferase 1
NM_000194 F = 5’-TGACACTGGCAAAACAATGCA-3’
R=5 ’-GGTCCTTTTCACCAGCAAGCT-3’
Nucleotide Salvaging:
Purine
synthesis
[8]
*RPL13a Ribosomal protein L13a NM_01242 F = 5’-CATAGGAAGCTGGGAGCAAG-3’
R=5 ’-GCCCTCCAATCAGTCTTCTG-3’
Translation
*YWHAZ Tyrosine 3-monooxygenase/tryptophan
5- monooxygenase activation
NM_003406
NM_145690
F=5 ’- TGCTTGCATCCCACAGACTA-3’
R=5 ’- AGGCAGACAATGACAGACCA-3’
Signal Transduction
UBC Ubiquitin C NM_021009 F = 5’-ATTTGGGTCGCGGTTCTTG-3’
R=5 ’-TGCCTTGACATTCTCGATGGT-3’
Protein Degradation [8]
Target Genes
CD31 Platelet/endothelial cell adhesion
molecule: PECAM1
NM_000442 F = 5’-AACAGTGTTGACATGAAGAGCC-3’
R=5 ’-TGTAAAACAGCACGTCATCCTT-3’
*LTBP2 Latent transforming growth factor
binding protein 2
NM_000428 F = 5’-GAGCCCAGCTGGAGTAGGA-3’
R=5 ’-AGCTTCTCTGAGTCTAGGGGG-3’
*STC1 Stanniocalcin 1 NM_003155 F = 5’-AGGCAAGGCTGACTTCTCTG-3’
R=5 ’-AACTACTTGTCGCATTGGGG-3’
*TSG6 Tumor necrosis factor, alpha- induced
protein 6 (TNFAIP6)
NM_007115 F = 5’-TCACATTTCAGCCACTGCTC-3’
R=5 ’-TGATCATATCGTCAGTTGTAGTGAA-3’
Rat Specific Normalization Genes
rRPL13a Ribosomal protein L13a NM_173340 F = 5’-GGCTGAAGCCTACCAGAAAG-3’
R=5 ’-CTTTGCCTTTTCCTTCCGTT-3’
Rat Specific Target Genes
rIGF1 Insulin-like growth factor 1
(somatomedin C), transcript variant 1-4
NM_178866
NM_001082477-
9
F=5 ’- GCTGAAGCCGTTCATTTAGC-3’
R=5 ’- GAGGAGGCCAAATTCAACAA-3’
rIGFBP3 Insulin-like growth factor binding
protein 3
NM_012588 F = 5’- CTCCATGTGCAGAGATGTCG-3’
R=5 ’- CTCTTTTGAAAGCTGCTCC-3’
rIGFBP5 Insulin-like growth factor binding
protein 5
NM_012817 F = 5’-AAGGAGACACTCCCCATTCC-3’
R=5 ’-TTCCCTTCTCTGTCCGTTCA-3’
Table#2: Primer pairs preceded by (*) are human species specific primer pairs
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(N-1) [ExpSTDEV/N-1]. EF1a (0.28) and RPL13a (0.29)
had the lowest average CP standard deviations. GAPDH
(1.11), which had the second highest relative expression
level, had the highest average CP standard deviation
between experiments. Therefore of the 8 genes tested,
EF1a and RPL13a had the highest gene stability (lowest
average CP standard deviation) during the expansion of
MIAMI cells under low oxygen conditions, while
GAPDH had the lowest gene stability (highest average
CP standard deviation) (Figure# 2). These results vali-
date EF1a and RPL13a as two candidate normalization
genes for RT-qPCR analysis of MIAMI cells. Addition-
ally, the high variability of GAPDH in MSC derived
MIAMI cells is contradictory to its common use in
human MSC research (Table 1).
To determine the effect of gene variability on the cal-
culation of a target genes change in expression, we used
the ΔΔCP method [13]. The average CP standard devia-
tion of the normalization gene was used to determine
the theoretical deviation on the target gene, calculated
as relative fold difference. The calculated theoretical
effects of normalization-gene variability on the target
genes fold difference are as follows: EF1a ±0 . 2 1 ,
RPL13a ± 0.22, YWHAZ ±0 . 3 1 ,B2M ± 0.33, ACTB ±
0.36, HPRT1 ± 0.38, UBC ±0 . 4 4a n dGAPDH ± 1.16.
These theoretical calculations take into account only the
effect of normalization gene variability, not the addi-
tional variability of any given target gene under experi-
mental conditions. Therefore, these data show that
normalization gene variability alone can impact a target
genes relative fold difference during RT-qPCR analysis,
as shown with the high fold variability of GAPDH com-
pared with EF1a and RPL13a.
Stability of EF1a and RPL13a as a function of oxygen
tension in MIAMI cells
EF1a and RPL13a were selected as two potential nor-
malization “housekeeping” genes based on their high
expression level and their stability during the expansion
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Figure 1 Relative mRNA expression levels of normalization
genes in MIAMI cells. MIAMI cells expanded under normal
expansion conditions (3% pO2) were harvested for total RNA. Real-
time RT-PCR analysis was conducted using 160 nM of both forward
and reverse primers with 50 ng of cDNA. Relative fold difference
was calculated using the ΔΔCt method [13,22]. N = 8 independent
experiments. HPRT1 was used as the relative control and was set to
the value of 1.
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Figure 2 EF1a and RPL13a have the lowest average CP standard deviation. Determination of the gene stability of 6 potential reference “
housekeeping” genes during the expansion of MIAMI cells at 3% pO2. The gene stability was determined by comparing the average CP
standard deviations for each gene between experiments. The average CP standard deviation was calculated by taking the summation of the CP
standard deviations of 8 independent experiments (2-3 data points per experiment) divided by N-1. N = 8 independent experiments.
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Page 4 of 15of MIAMI cells. The relative oxygen tension or partial
pressure of oxygen (pO2) in bone marrow ranges from
1% to 7%, while in arteries the pO2 can reach 10-12%
[14]. MIAMI cells undergo long term expansion and
self-renewal at 3% pO2, mimicking the hypothesized in
vivo niche environment, and require pO2 of 10-21% for
differentiation induction [3,15]. However, heterogeneous
non-selected MSC isolates are typically expanded and
differentiated at 21% pO2 [16].
We tested the stability of EF1a and RPL13a in 1, 3,
21% pO2 expansion conditions. All cell cultures were
expanded for at least two passages prior to RNA isola-
tion and RT-qPCR characterization. Our results showed
that the average standard CP deviation of EF1a
remained stable irrespective of oxygen tension (1%: 0.28,
3%: 0.34, 21%: 0.33) (Figure# 3). RPL13a had a
decreased average standard CP deviation at 1% (0.23)
and 21% (0.39) compared with 3% (0.53) pO2 (Figure#
3). Theoretically this would produce a change in the tar-
get genes calculated relative fold differences of ± 0.21-
0.26 for EF1a and ± 0.17-0.45 for RPL13a when charac-
terizing gene expression profiles of MIAMI cells
expanded under different pO2 expansion conditions.
Stability of EF1a and RPL13a during growth factor
treatment of MIAMI cells for neural precursor enrichment
MIAMI cells are able to differentiate into cells typical of
all three germ layers: endoderm, mesoderm and ecto-
derm [3]. In order to increase the pool of MIAMI neural
precursor cells and efficiency of neurotrophin-3 (NT3)
induced neuronal differentiation of MIAMI cells [17],
we expanded the cells for two 5-day periods in 3% pO2
with 20 ng/ml each of bFGF and EGF under normal
expansion conditions [3]. EF1a and RPL13a gene stabi-
lity were tested under normal expansion, treated with
bFGF alone or bFGF and EGF in combination. The
average CP standard deviation for EF1a (C: 0.21, bFGF:
0.16, bFGF/EGF: 0.14) and RPL13a (C: 0.24, bFGF: 0.15,
bFGF/EGF: 0.12) decreased with pretreatment (Figure#
4). The increased stability may be due to the formation
of a more homogeneous cell population under pretreat-
ment conditions, thereby decreasing the variability of
gene expression between cell cultures and experiments.
Functional assessment of EF1a, RPL13a, and GAPDH as
normalization genes during growth factor-induced
endothelial differentiation
We determined the functional use of EF1a and RPL13a
compared with the commonly used GAPDH as normali-
zation genes for RT-qPCR analysis using growth factor
induced endothelial differentiation of MIAMI cells. The
relative fold difference of the known endothelial marker
CD31 (PECAM-1: platelet endothelial cell adhesion
molecule), was calculated using the ΔΔCP method. The
data was normalized with EF1a, RPL13a,o rGAPDH
separately (Figure# 5A), or against the combined average
after normalization against EF1a and RPL13a,o rEF1a,
RPL13a, and GAPDH together (Figure# 5B).
Normalizing the RT-qPCR data against EF1a, RPL13a,
or GAPDH individually resulted in an increase of CD31
mRNA expression at day ten (over day 1) of, 1.53 ± 0.68,
2.25 ± 0.71, and 7.07 ± 4.93 relative fold difference, respec-
tively, and at day 21, 5.04 ± 0.88, 5.12 ± 1.3, and 17.49 ±
19.17 fold difference, respectively. The increase in CD31 at
Figure 3 Comparison of EF1a and RPL13a as a function of oxygen tension. Gene stability of EF1a and RPL13a during expansion of MIAMI
cells in different oxygen tensions. Gene stability was determined by comparing the average CP standard deviations for each gene between
MIAMI cells expanded at 1, 3, or 21% oxygen for at least 2 passages. The average CP standard deviation was calculated by taking the summation
of the CP standard deviations of 4 independent experiments (2-3 data points per experiment) divided by N-1. N = 4 independent experiments.
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cally significant (p ≤ 0.0005 and p ≤ 0.0028, respectively).
Due to the extremely high standard deviation, the relative
fold increase of CD31 at day 21 normalized against
GAPDH was not statistically significant (Figure# 5A).
We next analyzed the use of more than one normali-
zation gene for the analysis of RT-qPCR data as recom-
mended [8,9,18]. Using the combination of EF1a and
RPL13a as normalization genes, CD31 had a relative
fold increase at day ten of 1.89 ± 0.70, and 5.08 ± 1.09
at day 21 (p ≤ 0.002). Using EF1a, RPL13a, and GAPDH
together as normalization genes, CD31 had a fold
increase at day ten of 3.62 ± 2.11, and 9.21 ± 7.12 at
day 21, which was not statistically significant. In this
model of endothelial differentiation of MIAMI cells, the
increase of CD31 at day 21 normalized against both
EF1a and RPL13a was statistically significant (p ≤
0.002). When you add in the use of GAPDH,t h ef o l d
increase of CD31 at day 21 is not statistically significant
(Figure# 5B). From these results we show the functional-
ity of EF1a and RPL13a as normalization genes for the
R T - q P C Ra n a l y s i so fM I A M Ic e l l si nt h i se x a m p l eo f
endothelial differentiation.
Assessment of normalization genes used for the
detection of human-specific mRNA in a rat hippocampal
model of oxygen-glucose deprivation
In order to assess the role of MIAMI cells in an ex vivo
model of global cerebral ischemia (described in Xu et al.
2002 [19]) it is important to be able to characterize the spe-
cies-specific levels of mRNA expression. We created
human (h) and rat (r) species-specific primer pairs to deter-
mine the change in mRNA transcript levels of human
MIAMI cells injected into rat hippocampal organotypic
cultures during oxygen-glucose deprivation (40 min of
OGD). Primer pairs were constructed (refer to methods
section) for the human target genes; stanniocalcin 1
(hSTC1), tumor necrosis factor-inducible protein 6
(hTSG6), latent transforming growth factor beta binding
protein 2 (hLTBP2)a n dr a tt a r g e tg e n e s ;i n s u l i ng r o w t h
factor 1 (rIGF1), insulin growth factors binding proteins 3
and 5 (rIGFBP3 and rIGFBP5). Normalization “housekeep-
ing” genes were also constructed for rat RPL13a (rRPL13a),
and the previously described human specific normalization
genes; hRPL13a and hYWHAZ, were used for normaliza-
tion of human or rat RT-qPCR data (Table 2).
RT-qPCR analysis of human specific mRNA transcripts
normalized against both hRPL13a and hYWHAZ, detected
a 2.01, 2.74 and 1.62 fold increase for hSTC1, hTSG6, and
hLTBP2 respectively (Figure# 6A). There was no detected
change in hIGF1, hIGFBP3,a n dhIGFBP5 (Data not
shown). Analysis of rat specific mRNA transcripts normal-
ized against rRPL13a detected; no change in rIGF1,
rIGFBP3 increased (1.55 ± 0.08) after the injection of
MIAMI cells (compared to a media injected control), and
rIGFBP5 was found to decrease after induction of OGD
(-0.55 ± 0.26) with no change after injection of MIAMI
cells. These data show the construction and functional use
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Page 6 of 15of human and rat species-specific primer pairs for the ana-
lysis of mRNA expression levels in an ex vivo cross-species
animal model of global cerebral ischemia and tissue repair.
This technique will allow for the future analysis of MSC,
such as MIAMI cells, in animal models of tissue repair
and disease.
Comparison of 3 housekeeping genes in MIAMI cells, RS-
1 cell, and MSC
To further validate the use of RPL13a, EF1a,a n d
GAPDH as suitable normalization genes for RT-qPCR
analysis we compared MIAMI cells with commercially
available MSC (Lonza PT-2501: 21yo female) as well as
an adult stem cell population, similar to MIAMI cells,
derived from human MSC known as RS-1 cells (22 yo
male) [7]. RT-qPCR was used to determine the level
(CP) of expression for the 3 housekeeping genes, EF1a,
RPL13a,a n dGAPDH in MIAMI cells, RS-1 cells, and
commercially available MSC. EF1a and GAPDH had the
highest expression levels (lowest CP value) in MIAMI
cells expanded at 3% pO2 as compared with MIAMI
cells, RS-1 cells and commercially available MSC
expanded at 21% pO2 (Figure# 7A). RPL13a had a lower
average expression level (CP: 19.28 ± 0.20) in all 3 cell
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Figure 5 Validation of EF1a and RPL13a as normalization genes for RT-qPCR analysis of CD31 mRNA expression during the
endothelial differentiation of MIAMI cells. The relative fold difference in CD31 mRNA expression levels during the endothelial differentiation
of MIAMI cells was determined in order to test the functional use of EF1a and RPL13a as normalization genes for RT-qPCR analysis. Fold change
analysis was done using the ΔΔCt method [13,22] normalizing against EF1a, RPL13a, and GAPDH separately or by averaging the results
normalized against both EF1a and RPL13a or EF1a, RPL13a, and GAPDH together. Error bars are shown as standard deviation. All mRNA fold
difference and statistical calculations are done relative to Day 0 which is set to the value of 1 and is denoted by the dashed line in each graph.
N = 3 independent experiments.
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Page 7 of 15types compared to GAPDH (CP: 15.59 ± 0.46) and EF1a
(CP: 15.38 ± 0.23). There was no statistically significance
difference between the CP values of EF1a, RPL13a,o r
GAPDH between the 3 cells types.
The average CP standard deviation was used to com-
pare the stability of expression of EF1a, RPL13a,a n d
GAPDH between the 3 cell types (Figure# 7B). EF1a
and RPL13a had the lowest average CP standard devia-
tion: between MIAMI 3% pO2 (0.17 & 0.27), MIAMI
21% pO2 (0.09 & 0.13), RS-1 cells (0.02 & 0.07) and
MSC (0.06 & 0.07). The average CP standard deviation
of GAPDH was higher in MIAMI 3% pO2 (0.79),
MIAMI 21% pO2 (0.47) and MSC (0.47). In RS-1 cells
GAPDH did have a higher average CP standard devia-
tion (0.16) compared with EF1a and RPL13a,b u tt h e
increased value was not as large as seen with MIAMI
cells and MSC (Figure# 7B).
In order to determine the suitability of EF1a, RPL13a,
and GAPDH as housekeeping genes for comparison of
the different bone marrow derived stromal cell
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Page 8 of 15populations described above, RT-qPCR analysis was
used to compare the levels of human Telomerase
Reverse Transcriptase (hTeRT), which is essential for
the maintenance and propagation of telomeres.
Normalizing against RPL13a and EF1a individually,
hTeRT mRNA levels were significantly higher in MIAMI
cells expanded at 3% pO2 compared to RS-1 and
MIAMI cells expanded at 21% pO2. Normalizing the
RT-qPCR data against GAPDH alone showed no signifi-
cant change in hTeRT levels between the 3 cell types
(Figure# 7C). However using both EF1a and RPL13a in
combination for normalization resulted in hTeRT
mRNA levels significantly (p < 0.001) higher in MIAMI
cells expanded at low 3% pO2. The use of all 3
normalization genes, EF1a, RPL13a and GAPDH
together resulted in significance (p ≤ 0.001 vs. p ≤ 0.05)
when comparing hTeRT mRNA fold differences between
RS-1 cells and MIAMI cells expanded at 3% pO2.I n
addition, the use of all 3 genes for normalization
resulted in a lower level of hTeRT, with no significant
difference in MIAMI cells expanded at 3% pO2 versus
21% pO2 (Figure# 7D). Therefore, GAPDH is not a sui-
table RT-qPCR normalization gene either alone or in
combination with EF1a and or RPL13a.W h e r e a st h e
use of EF1a and RPL13a allowed for the reproducible
detection of hTeRT mRNA levels and both produced
the same relative results used alone or in combination
normalization genes (Figure# 7C &7D).
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The studies represented here show that EF1a and
RPL13a are two suitable and validated housekeeping
genes which can be used for the normalization of RT-
qPCR data. We have shown that EF1a and RPL13a both
have the lowest gene variability among 8 widely used
normalization genes and can be used reproducibly in
human bone marrow derived MIAMI cells under var-
ious expansion and differentiation conditions including;
expansion under low and high oxygen tension, endothe-
lial differentiation and neural precursor enrichment via
treatment with bFGF/EGF. Perhaps most important is
the comparison of commercially available MSC with
more primitive populations of MSC, such as MIAMI
a n dR S - 1c e l l s .H e r ew eh a v es h o w nt h a tEF1a and
RPL13a have low gene variability in MIAMI cells as well
as in RS-1 cells and in commercially available MSC, and
are suitable for the comparison of gene expression
between MSC derived populations, as shown with
hTeRT analysis. In addition, species-specific primer pairs
for human RPL13a and YWHAZ as well as rat RPL13a
were found to be suitable for RT-qPCR analysis in the
cross-species scenario of human MIAMI cells injected
into a rat hippocampal organotypic model of ischemia.
EF1a was not a candidate for human-rat species-specific
primer pair construction due to high sequence conserva-
tion between species.
The widely used housekeeping gene, GAPDH,w a s
found to have the highest level of gene instability out of
8 normalization genes tested in MIAMI cells. Moreover,
we observed a decrease in significant findings when
including GAPDH together with RPL13a and EF1a in
the normalization of CD31 and hTeRT mRNA analysis
of MIAMI cells, RS-1 cells, and MSC. We conclude that
GAPDH is not a reliable housekeeping gene for the nor-
malization of RT-qPCR data in human MSC research,
contradictory to its continued usage throughout this
field of research (Table 1).
MSC derived primarily from the bone marrow have
been examined extensively for their capacity to repair
damaged tissues. The potential clinical applications of
MSC are diverse, besides direct differentiation of the
adult stem cells into the desired mature cell type; other
indirect mechanisms have been identified to play impor-
tant roles in the overall repair of injured tissues, treat-
ment of autoimmune and chronic degenerative diseases.
Two possible mechanisms include the production of
paracrine factors or modulation of the host inflamma-
tory response [10,20]. In order to make comparisons
between heterogeneous MSC populations, as well as
more homogeneous adult stem cell like MSC which are
used in different laboratories throughout the world, it is
important to have a standardized, reproducible set of
housekeeping genes for RT-qPCR analysis. This will
allow for the comparison between the in vitro and in
vivo gene mRNA expression levels which would be
applicable to pre-clinical and clinical analyses of the
contribution of these genes to the tissue repair process
and functional outcomes.
In this study we demonstrate that EF1a and RPL13a
are two suitable genes for the RT-qPCR analysis and
comparison of several sources of human MSC. In addi-
tion, it should be noted that this study does not and
could not possibly encompass all experimental condi-
tions or MSC populations used throughout the field of
MSC research. With this in mind, it is important to
note that prior to collecting and or analyzing RT-qPCR
data, the housekeeping genes used for normalization
must be validated.
Conclusions
EF1a and RPL13a are suitable genes for normalization of
RT-qPCR analysis of MIAMI cells
EF1a and RPL13a have the lowest gene variability out of
8 genes tested for their use as normalization genes for
RT-qPCR analysis. GAPDH had the highest gene varia-
bility among the 8 genes tested. RPL13a and YWHAZ
were the best two genes to use for cross-species analysis
of human MIAMI cells injected into a rat animal model
of tissue damage, repair, and disease. EF1a and RPL13a
are two suitable genes which should be used as the
minimum normalization criteria for RT-qPCR analysis
of commercially available MSC, RS-1 cells, and MIAMI
during expansion, differentiation, and cross-species
analysis.
Methods
MIAMI Cell Isolation
Whole bone marrow was obtained from the iliac crest of
a 20 year old living male donor (Lonza Walkersville,
Maryland; MIAMI #3515), and were handled and pro-
cessed following the guidelines for informed consent set
by the University of Miami School of Medicine Commit-
tee on the Use of Human Subjects in Research. As pre-
viously described [3], isolated whole bone marrow cells
were plated at a constant density of 1 × 10
5 cells/cm
2 in
DMEM-low glucose media, containing 3% fetal bovine
serum (FBS, Hyclone Waltham, MA, Lot#30039), 20
mM ascorbic acid (Fluka/Sigma St. Louis, MO, #49752),
an essential fatty acid mixture (Sigma St. Louis, MO;
12.9 nM arachidonic acid, (#A9673), 1.12 μMc h o l e s -
terol (#C3045), 290 nM DL-alpha tocopherol-acetate
(#T3376), 85.9 nM myristic acid (#M3128), 69.4 nM
oleic acid (#01383), 76.5 nM palmitic acid (#P5585),
77.1 nM palmitoleic acid (P9417) and 68.9 nM stearic
acid (#S4751) (modified from [21]) and antibiotics
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Page 10 of 15(100 U/mL penicillin, 0.1 mg/mL streptomycin) (Gibco
Carlsbad, CA, #15140) on 10 ng/ml fibronectin (Sigma
S t .L o u i s ,M O ,# F 2 5 1 8 )c o a t e df l a s k s( N u n c l o n eR o c h e -
ster, NY). Whole bone marrow cells, containing adher-
ent and non-adherent cells, were incubated at 37°C
under hypoxic conditions (3% O2, 5% CO2 and 92% N2).
Seven days later, half of the culture medium was
replaced. Fourteen days after the initial plating, the non-
adherent cells were removed. Pooled colonies of adher-
ent cells were rinsed with PBS and plated at low density
for expansion (100 cells/cm
2)i n7 5c m
2 fibronectin
coated flasks.
MIAMI Cell Culture Conditions
MIAMI cells were grown in expansion media consisting
of DMEM-low glucose (as described above) in low oxy-
gen conditions (3% O2,5 %C O 2 and 92% N2). Media
was changed every 2-3 days and the cells were detached
and pelleted using trypsin (Gibco Carlsbad, CA, #25300)
upon reaching ~60% confluency. Peleted cells were
resuspended in media and plated in 10 ng/ml fibronec-
tin (Sigma St Louis, MO, #F2518) coated flasks (Nun-
clon, Rochester, NY) at 100 cells/cm
2.P r i o rt oR N A
isolation, adherent cells were rinsed 2× with PBS.
MIAMI cells expanded for 3 passages were character-
ized using flow cytometry and were positive for; MHC1,
CD29, CD81, CD90 and 50% positive for CD63, and
n e g a t i v ef o r ;M H C 2 ,H L A - D R ,C D 4 9 ,C D 1 0 9 ,C D 5 4 ,
CD56, CD36 (data not shown).
RS-1 Cell Culture Conditions
Human marrow stromal cells (hMSC, Donor#7081, 22yo
male) were obtained from the laboratory of Dr. Darwin
Prockop, Director, Texas A&M Health Science Center
College of Medicine Institute for Regenerative Medicine.
Bone marrow (BM) cells were isolated from human
donors according to guidelines on the Use of Human
Subjects in Research as described by all commercial ven-
dors. The hMSC were cultured in Alpha-Minimum
Essential medium (aMEM) with L-glutamine, but with
no ribonucleosides or deoxyribonucleosides (Invitrogen/
Gibco Carlsbad, CA, #12561-056), supplemented with
16.5% FBS (Hyclone Waltham, MA, #31752), 2 mM
GlutaMAX (#35050) and antibiotics (Gibco Carlsbad,
CA, #15140). To enrich for RS-1 cells, hMSC(P1) were
plated at 37°C under normoxic conditions (21% O2,5 %
CO2 and 74% N2) onto 10 ng/ml fibronectin (Sigma St.
Louis, MO, #F2518) coated flasks (Nunclon Rochester,
NY) overnight. The cells were detached using trypsin
(Gibco Carlsbad, CA #25300) and seeded at 50 cells/
cm
2. RS-1 enriched hMSCs were detached at 30-40%
confluency and re-plated at low density (50 cell/cm2)
[7]. RS-1 cells were harvested for RNA isolation at each
passage. MSC derived RS-1 cells, passage 2, were
positive for CD29, CD90, CD105 and CD73 as deter-
mined by Tulane University Center for Gene Therapy
(hMSCs #7801). RS-1 cells derived in our facilities, pas-
sage 3, were positive for; MHC1, CD81, CD90, CD29
(20%), CD63 (45%) and negative for; MHC2, HLA-DR,
CD49, CD109, CD54, CD56, CD36, as determined using
flow cytometry analysis (data not shown).
MSC Cell Culture Conditions
Human mesenchymal stem cells (MSC) derived from
the iliac crest were purchased from Lonza (Walkers-
ville, Maryland (PT-2501: 21yo female)). Bone marrow
(BM) cells were isolated from human donors according
to guidelines on the Use of Human Subjects in
Research as described by all commercial vendors. The
MSC were plated at 6,000 cells/cm
2 in DMEM-high
glucose media (Gibco Carlsbad, CA, #31053) supple-
mented with 15% FBS (Hyclone Waltham, MA,
#30039), ascorbic acid, antibiotics and essential fatty
acids (as described above), and expanded at 21% O2,
5% CO2 and 92% N2. The entire culture media was
changed every 3-4 days and the cells were detached
and replated every 7 days [16]. MSC purchased from
Lonza were positive for CD105, CD166, CD29, CD44,
and negative for; CD14, CD34 and CD45, as deter-
mined by flow cytometry (Lonza Wlkersville, Maryland
(Document # TS-PT-212-8 06/09).
Neural Pre-treatment
Epidermal growth factor (EGF) and basic fibroblast
growth factor (bFGF) treatment of MIAMI cells was
performed using 20 ng/mL each of EGF (#AF-100-15)
and bFGF (Peprotech Rocky Hill, NJ, #AF-100-18B)
alone or in combination. The pre-treated cells were
detached using trypsin and replated after day 5, followed
by a second 5 day pretreatment period. Pre-treated cells
were grown in expansion media under expansion condi-
tions (3% O2,5 %C O 2 and 92% N2). Media was changed
every 2-3 days and the cells were split using trypsin
(Gibco Carlsbad, CA, #25300) upon reaching ~60%
confluency.
Endothelial Differentiation
For endothelial differentiation, MIAMI cells were plated
at 20,000 cells/cm
2 in 6 well plates (Nunclone Roche-
ster, NY) in DMEM-low glucose media, containing 100
μM Ascorbic Acid, antibiotics, essential fatty acids,
angiogenic growth factor cocktail [Sigma St. Louis, MO:
10 ng/ml bFGF, 10 ng/ml EGF, 10 ng/ml IGF; R&D Sys-
tems, Inc. Minneapolis, MN: 100 ng/ml VEGF], 100 nM
Hydrocortisone, in atmosphere of 21% O2,5 %C O 2 and
incubated at 37°C for 21 days, with media changes every
5 days. Cells were harvested at day 10 and 21 and evalu-
ated by RT-qPCR for the endothelial marker CD 31.
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MIAMI cells were detached (Trypsin) and centrifuged to
form a cell pellet. RNA was isolated using the RNAqu-
eous® -4PCR kit (Ambion Austin, TX, #AM1914)
according to manufacturer’sd i r e c t i o n s .T o t a lR N Aw a s
quantified on the Nanodrop ND-1000 Spectrophot-
ometer (Nanodrop Wilmington, DE). Reverse transcrip-
tion of 2 μg total RNA to cDNA was done with random
hexamer primers using the High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems Foster
City, CA, #4368814). The cDNA was diluted 1:20
(Nuclease-Free Water: Gibco#10977-015) to a final
cDNA concentration of 5 ng/μl, aliqoted, and stored at
-20°C until next use. Only RNA with a 260/280 ratio
between 1.9-2.0 was used for PCR analysis.
Quantitative real-time RT-PCR (RT-qPCR)
Quantitative real-time PCR (RT-qPCR) was done using
10 μl of 1:20 diluted cDNA (50 ng) on the Mx3005P
Multiplex Quantitative PCR System (Stratagene#401513)
using RT-qPCR SYBR GREEN Reagents (Brilliant® II
SYBR® Green QPCR Master Mix, Agilent Technologies)
with ROX reference dye. Forward and reverse primer
pairs were reconstituted in Nuclease Free Water
(Gibco#10977-015). A 2 μM stock solution containing
both forward and reverse primer pairs was mixed and
stored at -20°C. A final concentration of 160 nM for-
ward and reverse primer pairs was used for each RT-
qPCR reaction. The cycling conditions were as follows:
an initial 95°C for 10 minutes, followed by 40 cycles of
95°C for 30 sec, 58°C for 30 sec, 72°C for 15 sec.
MxPro-Mx3005P v4.10 software was used to determine
the CP for each amplification reaction. Results were
exported to Microsoft Excel for analysis.
Analysis of RT-qPCR data
All of the corresponding RT-qPCR data was analyzed
using the ΔΔCP method [13] and normalized against
one negative control, and two reference genes (house-
keeping genes).
Relative Fold Difference
(Etarget) CP(target gene)(control
=
Δ - -sample)
(Ereference) CP(reference gene)(control-sample) Δ
The crossing point (CP) is defined as the point at
which the fluorescence rises appreciably above the back-
ground fluorescence. The ‘Fit Point Method’ was used
by the Mx3005P software to determine the CP for each
reaction. The control sample was set to a value of “1” in
all cases and error bars in the respective figures are dis-
played as standard deviation. The number of indepen-
dent experiments is designated as “N” with 2-3
individual data points collected per experiment.
Normalization Genes
Eight genes were tested for normalization [beta-actin
(ACTB, NM_001101), beta-2-microglobulin (B2M,
NM_004048), eukaryotic translational elongation factor
1a l p h a( EF1a, NM_001402), glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH, NM_002046), Hypox-
anthine phosphoribosyltransferase 1 (HPRT1,
NM_000194), ribosomal protein L13a (RPL13a,
NM_01242), tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta polypeptide var-
iant 1 & 2 (YWHAZ, NM_003406 & NM_145690), and
ubiquitin C (UBC, NM_021009)]. A list of primer pair
sequences used are in Table 1.
Determination of Primer Pair Efficiency
The determination of each genes’ primer pair efficiency
(E) for RT-qPCR was calculated using this equation: E =
10^(-1/m) [22]. The slope (m) was calculated by plotting
the cycle number crossing point (CP) calculated during
the exponential phase of the amplification plot (PxPro-
Mx3005P v4.10 software) against the total cDNA con-
centration. Concentrations of cDNA ranged from 50-1
ng per reaction. The percent efficiency (%E) was also
calculated: %E = (E-1)*100. N = 4 (2-3 data points per
experiment) (Additional file # 1).
Construction of species-specific primer pairs
In order to create species-specific primer pairs that
detect only human mRNA sequences or only rat mRNA
sequences within a human-rat cDNA library, the corre-
sponding human and rat mRNA sequences must have a
unique region of at least 60 bp or more. Using the
human and corresponding rat FASTA mRNA sequences
for EF1a, RPL13a and YWHAZ,w eu s e dB l a s t - nh t t p : / /
blast.ncbi.nlm.nih.gov/Blast.cgi to compare the
sequences. EF1a had 99% sequence coverage (100%
identity) between the human and rat mRNA sequences.
RPL13a had 57% sequence coverage (87% identity) and
YWHAZ transcript variants 1 and 2 had 92% - 63%
sequence coverage (100% identity). Therefore, RPL13a
and YWHAZ both were candidate human species-speci-
fic normalization genes while EF1a did not have a
region containing a unique sequence (≥60 bp) in order
to create primer pairs. Human species-specific primer
pairs were constructed for the 2 normalization genes;
RPL13a and YWHAZ and for 3 target genes; stanniocal-
cin-1 (STC-1), tumor necrosis factor, alpha-induced pro-
tein 6 (TSG6), and latent transforming growth factor
binding protein 2 (LTBP2). NCBI Primer-BLAST http://
www.ncbi.nlm.nih.gov/tools/primer-blast/ was used for
primer pair sequence construction [23] using the spe-
cies-unique mRNA sequences (FASTA format). Gradient
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Page 12 of 15PCR was used to determine optimum annealing tem-
perature. All human and rat specific primer pairs were
validated with RT-qPCR using cDNA from human
MIAMI cells H3515(3) or rat hippocampal organotypic
cultures either separately or in combination. All primer
pairs produced 1 species-specific amplicon, with mini-
mum off-target amplification. This was determined by
the melting curve of each amplification reaction (Addi-
tional File # 2) and agarose gel electrophoresis (data not
shown). Approximately 3-5 primer pairs were tested per
human or rat species-specific normalization or target
gene. All RT-qPCR results were normalized against a
negative control, and the 2 normalization genes
hRPL13a and hYWHAZ (human), or rRPL13a (rat).
Using this same method rat specific primer pairs were
also constructed for RPL13a, IGF1, IGFBP3,a n d
IGFBP5.
Model of ex vivo global cerebral ischemia for cross-
species RT-qPCR analysis
All animal experiments were performed according to
approved guidelines established by the University of
Miami IACUC. The rat hippocampal organotypic slice
preparation has been described in detail [19,24]. Briefly,
400 μm brain slices were obtained from rat pups of
either sex between postnatal days 9 and 10. Slices were
cultured for two weeks in a medium consisting of 25%
heat inactivated horse serum, 50% minimal essential
medium, and 25% Hank’s balanced salt solution, 5.5
mg/mL D-glucose and 1 mmol/L glutamine. For ische-
mia we used an established model consisting of com-
bined oxygen and glucose deprivation ([19,24]) during
40 mins. For OGD, oxygen is replaced with nitrogen
and glucose with sucrose. MIAMI cells were pre-treated
with bFGF and EGF (7 days: 50 ng/ml) prior to injection
in the CA1 region of the hippocampus (7,500 cells/μl
per injection (3 injections)). One hour after OGD induc-
tion and 24 hours after OGD total RNA was isolated
from rat hippocampal organotypic slice cultures
(described in [25]) with or without injected MIAMI. As
described previously, 2 μg of total RNA was used for
cDNA synthesis. RT-qPCR analysis was done using 5 μl
of undiluted cDNA. Human and rat specific primer
pairs are designated by (h) and (r) respectively (Table 2:
human specific primer pairs are designated by (*)).
Statistical Analysis
Only data sets containing N ≥ 3 independent experi-
ments (2-3 samples per condition per experiment) were
used for statistical analysis. A One-way ANOVA fol-
lowed by Tukey’s post-hoc analysis was used to calculate
statistical significance between conditions using Graph-
Pad Prism version 5.00 for Windows, GraphPad
Software, San Diego, CA, http://www.graphpad.com. All
error bars represent standard deviation.
Additional material
Additional file 1: Determination of Primer Pair Efficiency. Table
containing the calculated primer pair efficiency’s for the normalization
gene used during this study.
Additional file 2: Melting Curves for Species-Specific Primer Pairs.
This file containes the subsequent melting curves of the amplicons
generated from every primer pair used for RT-qPCR analysis to determine
specificity and off-target amplification.
Abbreviation list
MSC: Human bone marrow-derived multipotent mesenchymal stromal cells;
MIAMI CELLS: marrow isolated adult multilineage inducible; RS-1: rapidly self-
renewing; RT-qPCR: Quantitative real time RT-PCR; BFGF: basic fibroblast
growth factor; EGF: epidermal growth factor; VEGF: vascular endothelial
growth factor; OGD: oxygen-glucose deprivation;
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